Uniphos Enterprises Fair Value
Uniphos Enterprises (UNIENTER) average fair value is ₹938.5 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹105.13 (+792.7%), fair value range ₹0.34–₹2996.61. See UNIENTER P/B ratio history to compare market price against book value per share.
Fair Value Analysis Export
UNIENTER Fair Value vs Current Price — Valuation Summary
UNIENTER average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Examine UNIENTER earnings for recent quarterly revenue, profit and EPS trends.
P/E Based Valuation
P/B Based Valuation
Dividend Discount Model
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
UNIENTER Fair Value Analysis — Data Sources & Coverage
Uniphos Enterprises financial data sources, valuation methods applied and sector benchmarks used — 2003 financial year. For live price and a broader fundamental view, visit Uniphos Enterprises stock price NSE.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is 23 years old (2003).
UNIENTER vs Chemicals Sector Peers — P/E, P/B & Market Cap
Uniphos Enterprises P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Polychem | POLYCHEM | 2.78 | 1.38 | ₹82 |
| HP Adhesives | HPAL | 46.57 | 1.77 | ₹333 |
| Blue Pearl Agriventures | BPAGRI | 2082.0 | 20.57 | ₹1,192 |
| Omkar Pharmachem | OMKARPH | 337.5 | 2.86 | ₹27 |
| PB Global | PBGLOBAL | -0.06 | 0.01 | ₹0 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.